Back to search
Neisseria Meningitidis Serogroup B
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neisseria Meningitidis Serogroup B trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neisseria Meningitidis Serogroup B trials you may qualify forA randomized, double-blinded, positive-controlled clinical trial will be conducted to observe the safety and immunogenicity of DX-104 in adults 18 to 50 years o…
The goal of this clinical trial is to determine the immunogenicity of certain vaccines in protecting against meningitis B (MenB) in young adults who have previo…
The purpose of this study is to assess the safety and immune responses of rMenB+OMV NZ vaccine when administered to healthy infants from 2 months in the Republi…
This study is to look at a new vaccine that might prevent meningococcal disease, and to look at the safety of the new vaccine as well as how it is tolerated whe…